Search

Search Constraints

You searched for: Author/Creator Inanc, Nevsun

Search Results

2. 230. IS THE RISK OF TUBERCULOSIS INCREASED IN BEHÇET's DISEASE COMPARED TO OTHER RHEUMATOLOGICAL DISORDERS AFTER ANTI-TNF-A TREATMENT?. (29th March 2019)

3. AB0223 ASSESSMENT OF DISEASE ACTIVITY IN SYSTEMIC SCLEROSIS: THE COMPARISON BETWEEN REVISED EUSTAR AND ESCSG ACTIVITY INDEXES. (June 2019)

4. AB1242 COLCHICINE USE DURING PREGNANCY: CASE REPORTS. (June 2019)

6. After JAK inhibitor failure: to cycle or to switch, that is the question – data from the JAK-pot collaboration of registries. Issue 2 (13th September 2022)

7. Development of a new ultrasound scoring system to evaluate glandular inflammation in Sjögren's syndrome: an OMERACT reliability exercise. (25th November 2021)

8. Effectiveness of TNF-inhibitors, abatacept, IL6-inhibitors and JAK-inhibitors in 31 846 patients with rheumatoid arthritis in 19 registers from the 'JAK-pot' collaboration. Issue 10 (15th June 2022)

9. EULAR/eumusc.net standards of care for rheumatoid arthritis: cross-sectional analyses of importance, level of implementation and care gaps experienced by patients and rheumatologists across 35 European countries. Issue 11 (1st September 2020)

10. FRI0403 HIGH BASELINE PATIENT'S COMPARED WITH EVALUATOR'S GLOBAL ASSESSMENT IS ASSOCIATED WITH LOWER RETENTION AND REMISSION RATES OF FIRST TNF INHIBITOR IN AXSPA PATIENTS – DATA FROM THE EUROSPA COLLABORATION. (June 2019)